249 related articles for article (PubMed ID: 10677534)
1. Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis.
Kaminski N; Allard JD; Pittet JF; Zuo F; Griffiths MJ; Morris D; Huang X; Sheppard D; Heller RA
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1778-83. PubMed ID: 10677534
[TBL] [Abstract][Full Text] [Related]
2. Common and distinct mechanisms of induced pulmonary fibrosis by particulate and soluble chemical fibrogenic agents.
Dong J; Yu X; Porter DW; Battelli LA; Kashon ML; Ma Q
Arch Toxicol; 2016 Feb; 90(2):385-402. PubMed ID: 26345256
[TBL] [Abstract][Full Text] [Related]
3. Integrin-mediated activation of transforming growth factor-beta(1) in pulmonary fibrosis.
Sheppard D
Chest; 2001 Jul; 120(1 Suppl):49S-53S. PubMed ID: 11451914
[TBL] [Abstract][Full Text] [Related]
4. Molecular monitoring of bleomycin-induced pulmonary fibrosis by cDNA microarray-based gene expression profiling.
Katsuma S; Nishi K; Tanigawara K; Ikawa H; Shiojima S; Takagaki K; Kaminishi Y; Suzuki Y; Hirasawa A; Ohgi T; Yano J; Murakami Y; Tsujimoto G
Biochem Biophys Res Commun; 2001 Nov; 288(4):747-51. PubMed ID: 11688970
[TBL] [Abstract][Full Text] [Related]
5. The transcription factor NRF2 protects against pulmonary fibrosis.
Cho HY; Reddy SP; Yamamoto M; Kleeberger SR
FASEB J; 2004 Aug; 18(11):1258-60. PubMed ID: 15208274
[TBL] [Abstract][Full Text] [Related]
6. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
7. Expression of the human integrin beta6 subunit in alveolar type II cells and bronchiolar epithelial cells reverses lung inflammation in beta6 knockout mice.
Huang X; Wu J; Zhu W; Pytela R; Sheppard D
Am J Respir Cell Mol Biol; 1998 Oct; 19(4):636-42. PubMed ID: 9761761
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiles reveal molecular mechanisms involved in the progression and resolution of bleomycin-induced lung fibrosis.
Cabrera S; Selman M; Lonzano-Bolaños A; Konishi K; Richards TJ; Kaminski N; Pardo A
Am J Physiol Lung Cell Mol Physiol; 2013 May; 304(9):L593-601. PubMed ID: 23457188
[TBL] [Abstract][Full Text] [Related]
9. Transgenically-expressed secretoglobin 3A2 accelerates resolution of bleomycin-induced pulmonary fibrosis in mice.
Cai Y; Yoneda M; Tomita T; Kurotani R; Okamoto M; Kido T; Abe H; Mitzner W; Guha A; Kimura S
BMC Pulm Med; 2015 Jul; 15():72. PubMed ID: 26178733
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin D2 Attenuates Bleomycin-Induced Lung Inflammation and Pulmonary Fibrosis.
Kida T; Ayabe S; Omori K; Nakamura T; Maehara T; Aritake K; Urade Y; Murata T
PLoS One; 2016; 11(12):e0167729. PubMed ID: 27992456
[TBL] [Abstract][Full Text] [Related]
11. Relationships between early inflammatory response to bleomycin and sensitivity to lung fibrosis: a role for dipeptidyl-peptidase I and tissue inhibitor of metalloproteinase-3?
Pottier N; Chupin C; Defamie V; Cardinaud B; Sutherland R; Rios G; Gauthier F; Wolters PJ; Berthiaume Y; Barbry P; Mari B
Am J Respir Crit Care Med; 2007 Dec; 176(11):1098-107. PubMed ID: 17673693
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of epimorphin in bleomycin-induced pulmonary fibrosis in mice.
Terasaki Y; Fukuda Y; Ishizaki M; Yamanaka N
Am J Respir Cell Mol Biol; 2000 Aug; 23(2):168-74. PubMed ID: 10919982
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of developmental endothelial locus-1 (Del-1) aggravates bleomycin-induced pulmonary fibrosis in mice.
Kang YY; Kim DY; Lee SH; Choi EY
Biochem Biophys Res Commun; 2014 Mar; 445(2):369-74. PubMed ID: 24525119
[TBL] [Abstract][Full Text] [Related]
14. Fine mapping of the major bleomycin-induced pulmonary fibrosis susceptibility locus in mice.
Bergeron ME; Stefanov A; Haston CK
Mamm Genome; 2018 Oct; 29(9-10):670-679. PubMed ID: 30173367
[TBL] [Abstract][Full Text] [Related]
15. Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin (BLM) via suppressing pro-fibrotic and inflammatory signaling pathways.
Dong SH; Liu YW; Wei F; Tan HZ; Han ZD
Biomed Pharmacother; 2017 May; 89():1297-1309. PubMed ID: 28320097
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-converting enzyme-1 gene ablation attenuates pulmonary fibrosis via CGRP-cAMP/EPAC1 pathway.
Hartopo AB; Emoto N; Vignon-Zellweger N; Suzuki Y; Yagi K; Nakayama K; Hirata K
Am J Respir Cell Mol Biol; 2013 Apr; 48(4):465-76. PubMed ID: 23306833
[TBL] [Abstract][Full Text] [Related]
17. A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice.
Takemasa A; Ishii Y; Fukuda T
Eur Respir J; 2012 Dec; 40(6):1475-82. PubMed ID: 22441751
[TBL] [Abstract][Full Text] [Related]
18. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.
Swaisgood CM; French EL; Noga C; Simon RH; Ploplis VA
Am J Pathol; 2000 Jul; 157(1):177-87. PubMed ID: 10880388
[TBL] [Abstract][Full Text] [Related]
19. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.
Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corcetto F; Corno C; Maneschi E; Pini A; Adorini L; Vannelli GB; Maggi M; Vignozzi L
J Steroid Biochem Mol Biol; 2017 Apr; 168():26-37. PubMed ID: 28115235
[TBL] [Abstract][Full Text] [Related]
20. Enhanced endogenous bone morphogenetic protein signaling protects against bleomycin induced pulmonary fibrosis.
De Langhe E; Cailotto F; De Vooght V; Aznar-Lopez C; Vanoirbeek JA; Luyten FP; Lories RJ
Respir Res; 2015 Mar; 16(1):38. PubMed ID: 25849157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
